Available Forms: Prefilled syringe
Available Strengths: 225 mg / 1.5 mL
Reference Brands: Ajovy (USA/EU)
Category: Neurology
Fremanezumab is a monoclonal antibody that targets the CGRP receptor, a protein involved in the transmission of pain and the development of migraines. By inhibiting this receptor, fremanezumab helps to prevent the onset of migraine attacks. It is administered via subcutaneous injection, with dosing options tailored to patient needs and preferences.
Quick Response Guaranteed | Verified Suppliers
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online · B2B Pharma · Medical Tourism · NPP